Literature DB >> 26081349

The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.

Takashi Kurita1, Shinsuke Yasuda1, Koji Oba2, Toshio Odani1, Michihito Kono1, Kotaro Otomo1, Yuichiro Fujieda1, Kenji Oku1, Toshiyuki Bohgaki1, Olga Amengual1, Tetsuya Horita1, Tatsuya Atsumi1.   

Abstract

Entities:  

Year:  2015        PMID： 26081349     DOI： 10.1093/rheumatology/kev192

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Combination therapy of tacrolimus, high doses of glucocorticosteroids, and cyclophosphamide against existing historical treatment for patients in severe conditions of interstitial lung diseases complicated with dermatomyositis: A retrospective analysis.

Authors:  Lian Li; Mu Li; Yingchun Li; Kang Wang; Shengqian Xu
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

Review 2.  Polymyositis as a paraneoplastic syndrome of a patient with primary pulmonary lymphoepithelioma-like carcinoma: a case report and literature review.

Authors:  Yu Lei; Caiyang Liu; Xiu Wan; Yanhui Yang; Yi Yao; Lei Luo; Tingyu Huang; Ji Li
Journal:  J Cardiothorac Surg       Date:  2022-05-17       Impact factor: 1.522

Review 3.  Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.

Authors:  Kun Huang; Ophir Vinik; Kam Shojania; James Yeung; Rachel Shupak; Michael Nimmo; J Antonio Avina-Zubieta
Journal:  Rheumatol Int       Date:  2019-08-02       Impact factor: 2.631

Review 4.  Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management.

Authors:  Robert W Hallowell; Julie J Paik
Journal:  Clin Exp Rheumatol       Date:  2021-03-25       Impact factor: 4.473

5.  Factors associated with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies.

Authors:  Yawen Zhao; Wei Zhang; Yilin Liu; Zhaoxia Wang; Yun Yuan
Journal:  Orphanet J Rare Dis       Date:  2020-07-08       Impact factor: 4.123

6.  The relationship between high-dose corticosteroid treatment and mortality in acute respiratory distress syndrome: a retrospective and observational study using a nationwide administrative database in Japan.

Authors:  Takashi Kido; Keiji Muramatsu; Takeshi Asakawa; Hiroki Otsubo; Takaaki Ogoshi; Keishi Oda; Tatsuhiko Kubo; Yoshihisa Fujino; Shinya Matsuda; Toshihiko Mayumi; Hiroshi Mukae; Kazuhiro Yatera
Journal:  BMC Pulm Med       Date:  2018-02-07       Impact factor: 3.317

7.  Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway.

Authors:  Sigong Zhang; Xueqin Jia; Qiuyue Zhang; Li Zhang; Jing Yang; Caihong Hu; Junnian Shi; Xiao Jiang; Jinyue Lu; Haili Shen
Journal:  J Cell Mol Med       Date:  2019-12-10       Impact factor: 5.310

8.  KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis.

Authors:  Tao Zhang; Ping Shen; Chunyan Duan; Lingyun Gao
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.